US Patent 11583529 Treatment of inflammatory disorders
Patent 11583529 was granted and assigned to Aldeyra Therapeutics on February, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11583529 Treatment of inflammatory disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
